Anne-Kristina Mercier

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Chronic Kidney Disease

Placebo Controlled

Top Venues

Clinical pharmacology and therapeutics

Journal of the American Society of Nephrology : JASN

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Anne-Kristina Mercier, Sebastian Ueckert, Mikael Sunnåker, Bengt Hamrén, Philip Ambery, Peter J Greasley, Magnus Åstrand
From Plan to Pivot: How Model-Informed Drug Development Shaped the Dose Strategy of the Zibotentan/Dapagliflozin ZENITH Trials. Clinical pharmacology and therapeutics 116 (3) (2024)
Anne-Kristina Mercier, Abigail K Kois, Deeyen Karsanji, Richard Baldry, Filip Birve, Maria Hedwall, Oleksandr Molodetskyi, Michael Gillen
Zibotentan Can Be Co-administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug-Drug Interaction Study. Clinical pharmacology and therapeutics 116 (2) (2024)
J David Smeijer, Victor S Wasehuus, Neeraj Dhaun, Jose Luis Gorriz Teruel, Maria José Soler, Magnus Åstrand, Anne-Kristina Mercier, Peter J Greasley, Philip Ambery, Hiddo J Lambers Heerspink
Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD. Journal of the American Society of Nephrology : JASN (2024)
Anne-Kristina Mercier, Abigail K Kois, Deeyen Karsanji, Richard Baldry, Filip Birve, Maria Hedwall, Oleksandr Molodetskyi, Michael Gillen
Zibotentan Can Be Co-administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug-Drug Interaction Study. Clinical pharmacology and therapeutics (2024)
Anne-Kristina Mercier, Sebastian Ueckert, Mikael Sunnåker, Bengt Hamrén, Philip Ambery, Peter J Greasley, Magnus Åstrand
From Plan to Pivot: How Model-Informed Drug Development Shaped the Dose Strategy of the Zibotentan/Dapagliflozin ZENITH Trials. Clinical pharmacology and therapeutics (2024)
Anne-Kristina Mercier, Mikael Sunnåker, Sebastian Ueckert, Tadeusz Pawlik, Emilia Henricson, Oleksandr Molodetskyi, Gordon C Law, Victoria E R Parker, Jan Oscarsson
Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic Impairment. Clinical pharmacokinetics (2023)